Abstract
Brains suffering from Alzheimer’s disease show pronounced morphological modifications, with ample volumetric reduction of neural tissue. While particularly visible during the most severe disease stages, these changes are more subtle at the prodromal stage, which is the moment when a clinical diagnosis should be ideally reached. A large body of research has tried to disentangle the nature of such modifications, modeling the regional anatomical variability observed at various disease stages in samples and cohorts, implementing a number of different methodological avenues. The result is a complex picture in which brain morphology is not exclusively affected by disease processes, but is also under the influence of a large series of additional variables, which all contribute to the resulting phenotype via a tight network of multiple biological mechanisms. As a consequence, the study of morphological changes in AD highlights a sensible lack of clinical specificity. Despite these limitations, however, a large body of publications has highlighted the importance of brain morphology for the characterization of different phenotypic expressions of this disease and for the quantification of treatment effects.
“(…) the monster got part of your wonderful brain. But what did you ever get from him?”
Inga, Young Frankenstein, 1974
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Opara JA (2012) Activities of daily living and quality of life in Alzheimer disease. J Med Life 5:162–167
Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement 3:186–191
Ehret MJ, Chamberlin KW (2015) Current practices in the treatment of Alzheimer disease: where is the evidence after the phase III trials? Clin Ther 37:1604–1616
Strimbu K, Tavel JA (2010) What are biomarkers? Curr Opin HIV AIDS 5:463–466
Blennow K, Zetterberg H (2015) The past and the future of Alzheimer’s disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events. Front Neurosci 9:345
Adlard PA, Tran BA, Finkelstein DI et al (2014) A review of β-amyloid neuroimaging in Alzheimer’s disease. Front Neurosci 8:327
Okamura N, Harada R, Furumoto S, Arai H, Yanai K, Kudo Y (2014) Tau PET imaging in Alzheimer’s disease. Curr Neurol Neurosci Rep 14:500
Besson JAO, Corrigan FM, Foreman EI, Eastwood LM, Smith FW, Ashcroft GW (1984) Proton NMR observations in dementia. Magn Reson Med 1:106–107
Brun A, Englund E (1986) Brain changes in dementia of Alzheimer’s type relevant to new imaging diagnostic methods. Prog Neuro-Psychopharmacol Biol Psychiatry 10:297–308
George AE, de Leon MJ, Stylopoulos LA et al (1990) CT diagnostic features of Alzheimer disease: importance of the choroidal/hippocampal fissure complex. Am J Neuroradiol 11:101–107
Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL (1984) Alzheimer’s disease: cell-specific pathology isolates the hippocampal formation. Science 225:1168–1170
Jernigan TL, Salmon DP, Butters N, Hesselink JR (1991) Cerebral structure on MRI, part II: specific changes in Alzheimer’s and Huntington’s diseases. Biol Psychiatry 29:68–81
Alzheimer’s Society UK. Dementia Infographic (2013). https://www.alzheimers.org.uk/site/scripts/download_info.php?fileID=1409
Tuokkola T, Koikkalainen J, Parkkola R, Karrasch M, Lötjönen J, Rinne JO (2016) Visual rating method and tensor-based morphometry in the diagnosis of mild cognitive impairment and Alzheimer’s disease: a comparative magnetic resonance imaging study. Acta Radiol 57:348–355
Pasquier F, Leys D, Weerts JG, Mounier-Vehier F, Barkhof F, Scheltens P (1996) Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 36:268–272
Juottonen K, Laakso MP, Partanen K, Soininen H (1999) Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. Am J Neuroradiol 20:139–144
Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577
Tanabe JL, Amend D, Schuff N et al (1997) Tissue segmentation of the brain in Alzheimer disease. Am J Neuroradiol 18:115–123
Ferreira LK, Diniz BS, Forlenza OV, Busatto GF, Zanetti MV (2011) Neurostructural predictors of Alzheimer’s disease: a meta-analysis of VBM studies. Neurobiol Aging 32:1733–1741
Yoon B, Shim YS, Hong YJ et al (2011) Comparison of diffusion tensor imaging and voxel-based morphometry to detect white matter damage in Alzheimer’s disease. J Neurol Sci 302:89–95
Busatto GF, Diniz BS, Zanetti MV (2008) Voxel-based morphometry in Alzheimer’s disease. Expert Rev Neurother 8:1691–1702
Li C, Wang J, Gui L, Zheng J, Liu C, Du H (2011) Alterations of whole-brain cortical area and thickness in mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis 27:281–290
Arbabshirani MR, Plis S, Sui J, Calhoun VD (2017) Single subject prediction of brain disorders in neuroimaging: promises and pitfalls. NeuroImage 145:137–165
Kim CM, Hwang J, Lee JM et al (2015) Amyloid beta-weighted cortical thickness: a new imaging biomarker in Alzheimer’s disease. Curr Alzheimer Res 12:563–571
Montembeault M, Rouleau I, Provost JS, Brambati SM, Alzheimer’s Disease Neuroimaging Initiative (2016) Altered gray matter structural covariance networks in early stages of Alzheimer’s disease. Cereb Cortex 26:2650–2662
Cardoso MJ, Leung K, Modat M et al (2013) STEPS: similarity and truth estimation for propagated segmentations and its application to hippocampal segmentation and brain parcelation. Med Image Anal 17:671–684
Ben Ahmed O, Mizotin M, Benois-Pineau J et al (2015) Alzheimer’s disease diagnosis on structural MR images using circular harmonic functions descriptors on hippocampus and posterior cingulate cortex. Comput Med Imaging Graph 44:13–25
Miller MI, Younes L, Ratnanather JT et al (2015) Amygdalar atrophy in symptomatic Alzheimer’s disease based on diffeomorphometry: the BIOCARD cohort. Neurobiol Aging 36:S3–S10
Zhang Y, Dong Z, Phillips P et al (2015) Detection of subjects and brain regions related to Alzheimer’s disease using 3D MRI scans based on eigenbrain and machine learning. Front Comput Neurosci 9:66
Wisse LE, Biessels GJ, Heringa SM et al (2014) Hippocampal subfield volumes at 7T in early Alzheimer’s disease and normal aging. Neurobiol Aging 35:2039–2045
Joshi A, Ringman JM, Lee AS, Juarez KO, Mendez MF (2012) Comparison of clinical characteristics between familial and non-familial early onset Alzheimer’s disease. J Neurol 259:2182–2188
Tellechea P, Pujol N, Esteve-Belloch P et al (2015) Early- and late-onset Alzheimer disease: are they the same entity? [Article in English, Spanish] Neurologia. pii: S0213-4853(15)00210-8. doi: https://doi.org/10.1016/j.nrl.2015.08.002
Karantzoulis S, Galvin JE (2011) Distinguishing Alzheimer’s disease from other major forms of dementia. Expert Rev Neurother 11:1579–1591
Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW (2011) Neuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10:785–796
La Joie R, Perrotin A, Barré L et al (2012) Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer’s disease dementia. J Neurosci 32:16265–16273
Putcha D, Brickhouse M, O’Keefe K et al (2011) Hippocampal hyperactivation associated with cortical thinning in Alzheimer’s disease signature regions in non-demented elderly adults. J Neurosci 31:17680–17688
Sperling RA, Dickerson BC, Pihlajamaki M et al (2010) Functional alterations in memory networks in early Alzheimer’s disease. NeuroMolecular Med 12:27–43
Tahmasian M, Pasquini L, Scherr M et al (2015) The lower hippocampus global connectivity, the higher its local metabolism in Alzheimer disease. Neurology 84:1956–1963
McDonald CR, McEvoy LK, Gharapetian L et al (2009) Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology 73:457–465
Im K, Lee JM, Seo SW et al (2008) Variations in cortical thickness with dementia severity in Alzheimer’s disease. Neurosci Lett 436:227–231
Greicius MD, Srivastava G, Reiss AL, Menon V (2004) Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A 101:4637–4642
Sperling RA, Laviolette PS, O’Keefe K et al (2009) Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 63:178–188
Gispert JD, Rami L, Sánchez-Benavides G et al (2015) Nonlinear cerebral atrophy patterns across the Alzheimer’s disease continuum: impact of APOE4 genotype. Neurobiol Aging 36:2687–2701
Dubois B, Feldman HH, Jacova C et al (2014) Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 13(6):614–629
McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269
Albert MS, DeKosky ST, Dickson D et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:270–279
Peters R (2006) Ageing and the brain. Postgrad Med J 82:84–88
Stark AK, Toft MH, Pakkenberg H et al (2007) The effect of age and gender on the volume and size distribution of neocortical neurons. Neuroscience 150:121–130
Jacobs B, Schall M, Prather M et al (2001) Regional dendritic and spine variation in human cerebral cortex: a quantitative golgi study. Cereb Cortex 11:558–571
Morrison JH, Baxter MG (2012) The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat Rev Neurosci 13:240–250
Wignall EL, Dickson JM, Vaughan P et al (2004) Smaller hippocampal volume in patients with recent-onset posttraumatic stress disorder. Biol Psychiatry 56:832–836
Labate A, Cerasa A, Gambardella A, Aguglia U, Quattrone A (2008) Hippocampal and thalamic atrophy in mild temporal lobe epilepsy: a VBM study. Neurology 71:1094–1101
Bell-McGinty S, Butters MA, Meltzer CC, Greer PJ, Reynolds CF 3rd, Becker JT (2002) Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry 159:1424–1427
Moulton CD, Costafreda SG, Horton P, Ismail K, CH F (2015) Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes. Brain Imaging Behav 9:651–662
Tarroun A, Bonnefoy M, Bouffard-Vercelli J, Gedeon C, Vallee B, Cotton F (2007) Could linear MRI measurements of hippocampus differentiate normal brain aging in elderly persons from Alzheimer disease? Surg Radiol Anat 29:77–81
Walhovd KB, Westlye LT, Amlien I et al (2011) Consistent neuroanatomical age-related volume differences across multiple samples. Neurobiol Aging 32:916–932
Fjell AM, Westlye LT, Grydeland H et al (2014) Accelerating cortical thinning: unique to dementia or universal in aging? Cereb Cortex 24:919–934
Wang L, Benzinger TL, Hassenstab J et al (2015) Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease. Neurology 84:1254–1260
Araque Caballero MÁ, Brendel M, Delker A et al (2015) Alzheimer’s disease neuroimaging initative (ADNI). mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects. Neurobiol Aging 36:2913–2924
Whitwell JL, Tosakulwong N, Weigand SD et al (2013) Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects? Neuroimage Clin 2:249–257
Rabinowicz T, Dean DE, Petetot JM, de Courten-Myers GM (1999) Gender differences in the human cerebral cortex: more neurons in males; more processes in females. J Child Neurol 14:98–107
De Marco M, Venneri A (2015) ‘O’ blood type is associated with larger grey-matter volumes in the cerebellum. Brain Res Bull 116:1–6
O’Dwyer L, Lamberton F, Matura S et al (2012) Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study. PLoS One 7:e48895
Sala-Llonch R, Lladó A, Fortea J et al (2015) Evolving brain structural changes in PSEN1 mutation carriers. Neurobiol Aging 36:1261–1270
Allan CL, Zsoldos E, Filippini N et al (2015) Lifetime hypertension as a predictor of brain structure in older adults: cohort study with a 28-year follow-up. Br J Psychiatry 206:308–315
Whitlow CT, Sink KM, Divers J et al (2015) Effects of type 2 diabetes on brain structure and cognitive function: African American-Diabetes Heart Study MIND. Am J Neuroradiol 36:1648–1653
Stern Y (2009) Cognitive reserve. Neuropsychologia 47:2015–2028
Cho H, Jeon S, Kim C et al (2015) Higher education affects accelerated cortical thinning in Alzheimer’s disease: a 5-year preliminary longitudinal study. Int Psychogeriatr 27:111–120
Gaser C, Schlaug G (2003) Brain structures differ between musicians and non-musicians. J Neurosci 23:9240–9245
Maguire EA, Spiers HJ, Good CD, Hartley T, Frackowiak RS, Burgess N (2003) Navigation expertise and the human hippocampus: a structural brain imaging analysis. Hippocampus 13:250–259
Lövdén M, Bäckman L, Lindenberger U, Schaefer S, Schmiedek F (2010) A theoretical framework for the study of adult cognitive plasticity. Psychol Bull 136:659–676
Takeuchi H, Taki Y, Hashizume H et al (2011) Effects of training of processing speed on neural systems. J Neurosci 31:12139–12148
Mesulam MM (1999) Neuroplasticity failure in Alzheimer’s disease: bridging the gap between plaques and tangles. Neuron 24:521–529
Byun MS, Kim SE, Park J et al (2015) Heterogeneity of regional brain atrophy patterns associated with distinct progression rates in Alzheimer’s disease. PLoS One 10:e0142756
Masliah E, Hansen LA (2011) Alzheimer disease: AD pathology—emerging subtypes or age-of-onset spectrum? Nat Rev Neurol 8:11–12
Ge YL, Grossman RI, Babb JS, Rabin ML, Mannon LJ, Kolson DL (2002) Age-related total gray matter changes in normal adult brain. Part I: volumetric MR imaging analysis. Am J Neuroradiol 23:1327–1333
Hasan KM, Mwangi B, Cao B et al (2016) Entorhinal cortex thickness across the human lifespan. J Neuroimaging 26:95–102
Jack CR Jr, Petersen RC, Xu YC et al (1997) Medial temporal atrophy on MRI in normal aging and very mild Alzheimer’s disease. Neurology 49:786–794
Risacher SL, Saykin AJ, West JD et al (2009) Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res 6:347–361
Spulber G, Niskanen E, Macdonald S et al (2012) Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD. Curr Alzheimer Res 9:516–524
Venneri A, Gorgoglione G, Toraci C, Nocetti L, Panzetti P, Nichelli P (2011) Combining neuropsychological and structural neuroimaging indicators of conversion to Alzheimer’s disease in amnestic mild cognitive impairment. Curr Alzheimer Res 8:789–797
Beltrachini L, De Marco M, Taylor ZA, Lotjonen J, Frangi AF, Venneri A (2015) Integration of cognitive tests and resting state fMRI for the individual identification of mild cognitive impairment. Curr Alzheimer Res 12:592–603
Westman E, Muehlboeck JS, Simmons A (2012) Combining MRI and CSF measures for classification of Alzheimer’s disease and prediction of mild cognitive impairment conversion. NeuroImage 62:229–238
Yun HJ, Kwak K, Lee JM, Alzheimer’s Disease Neuroimaging Initiative (2015) Multimodal discrimination of Alzheimer’s disease based on regional cortical atrophy and hypometabolism. PLoS One 10:e0129250
Mattay VS, Goldberg TE, Sambataro F, Weinberger DR (2008) Neurobiology of cognitive aging: insights from imaging genetics. Biol Psychol 79:9–22
Tyler LK, Marslen-Wilson W, Stamatakis EA (2005) Dissociating neuro-cognitive component processes: voxel-based correlational methodology. Neuropsychologia 43:771–778
Grossman M, McMillan C, Moore P et al (2004) What’s in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer’s disease, frontotemporal dementia and corticobasal degeneration. Brain 127:628–649
Pennington C, Hodges JR, Hornberger M (2011) Neural correlates of episodic memory in behavioral variant frontotemporal dementia. J Alzheimers Dis 24:261–268
Nho K, Risacher SL, Crane PK et al (2012) Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer’s disease. Brain Imaging Behav 6:551–567
Rodríguez-Ferreiro J, Cuetos F, Monsalve A, Martínez C, Perez AJ, Venneri A (2012) Establishing the relationship between cortical atrophy and semantic deficits in Alzheimer’s disease and mild cognitive impairment patients through voxel-based morphometry. J Neuroling 25:139–149
Belleville S, Clément F, Mellah S, Gilbert B, Fontaine F, Gauthier S (2011) Training-related brain plasticity in subjects at risk of developing Alzheimer’s disease. Brain 134:1623–1634
Venneri A, McGeown WJ, Hietanen HM, Guerrini C, Ellis AW, Shanks MF (2008) The anatomical bases of semantic retrieval deficits in early Alzheimer’s disease. Neuropsychologia 46:497–510
Thomann PA, Toro P, Dos Santos V, Essig M, Schröder J (2008) Clock drawing performance and brain morphology in mild cognitive impairment and Alzheimer’s disease. Brain Cogn 67:88–93
Bruen PD, McGeown WJ, Shanks MF, Venneri A (2008) Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer’s disease. Brain 131:2455–2463
Scahill RI, Ridgway GR, Bartlett JW et al (2013) Genetic influences on atrophy patterns in familial Alzheimer’s disease: a comparison of APP and PSEN1 mutations. J Alzheimers Dis 35:199–212
Mahley RW, Weisgraber KH, Huang Y (2006) Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer’s disease. Proc Natl Acad Sci U S A 103:5644–5651
Filippini N, Rao A, Wetten S et al (2009) Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer’s disease. NeuroImage 44:724–728
Pievani M, Galluzzi S, Thompson PM, Rasser PE, Bonetti M, Frisoni GB (2011) APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer’s disease. NeuroImage 55:909–919
Biffi A, Anderson CD, Desikan RS et al (2010) Genetic variation and neuroimaging measures in Alzheimer disease. Arch Neurol 67:677–685
Lambert JC, Ibrahim-Verbaas CA et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45:1452–1458
Hibar DP, Stein JL, Kohannim O et al (2011) Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects. NeuroImage 56:1875–1891
Hibar DP, Stein JL, Jahanshad N et al (2015) Genome-wide interaction analysis reveals replicated epistatic effects on brain structure. Neurobiol Aging 36:S151–S158
Di Marco LY, Venneri A, Farkas E, Evans PC, Marzo A, Frangi AF (2015) Vascular dysfunction in the pathogenesis of Alzheimer’s disease—a review of endothelium-mediated mechanisms and ensuing vicious circles. Neurobiol Dis 82:593–606
Wang R, Fratiglioni L, Laveskog A et al (2014) Do cardiovascular risk factors explain the link between white matter hyperintensities and brain volumes in old age? A population-based study. Eur J Neurol 21:1076–1082
Steffener J, Stern Y (2012) Exploring the neural basis of cognitive reserve in aging. Biochim Biophys Acta 1822:467–473
Wang L, Harms MP, Staggs JM et al (2010) Donepezil treatment and changes in hippocampal structure in very mild Alzheimer disease. Arch Neurol 67:99–106
Krishnan KR, Charles HC, Doraiswamy PM et al (2003) Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer’s disease. Am J Psychiatry 160:2003–2011
Hashimoto M, Kazui H, Matsumoto K, Nakano Y, Yasuda M, Mori E (2005) Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer’s disease? Am J Psychiatry 162:676–682
Dubois B, Chupin M, Hampel H et al (2015) Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer’s disease. Alzheimers Dement 11:1041–1049
Jack CR Jr, Petersen RC, Grundman M et al (2008) Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging 29:1285–1295
Schuff N, Suhy J, Goldman R et al (2011) An MRI substudy of a donepezil clinical trial in mild cognitive impairment. Neurobiol Aging 32:2318.e31–2318.e41
Tanaka Y, Hanyu H, Sakurai H, Takasaki M, Abe K (2003) Atrophy of the substantia innominata on magnetic resonance imaging predicts response to donepezil treatment in Alzheimer’s disease patients. Dement Geriatr Cogn Disord 16:119–125
Kanetaka H, Hanyu H, Hirao K et al (2008) Prediction of response to donepezil in Alzheimer’s disease: combined MRI analysis of the substantia innominata and SPECT measurement of cerebral perfusion. Nucl Med Commun 29:568–573
Bottini G, Berlingeri M, Basilico S et al (2012) GOOD or BAD responder? Behavioural and neuroanatomical markers of clinical response to donepezil in dementia. Behav Neurol 25:61–72
Csernansky JG, Wang L, Miller JP, Galvin JE, Morris JC (2005) Neuroanatomical predictors of response to donepezil therapy in patients with dementia. Arch Neurol 62:1718–1722
Prins ND, van der Flier WA, Knol DL et al (2014) The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial. Alzheimers Res Ther 6:47
Venneri A, McGeown WJ, Shanks MF (2005) Empirical evidence of neuroprotection by dual cholinesterase inhibition in Alzheimer’s disease. Neuroreport 16:107–110
Weiner MW, Sadowsky C, Saxton J et al (2011) Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer’s disease. Alzheimers Dement 7:425–435
Fox NC, Black RS, Gilman S et al (2005) AN1792(QS-21)-201 Study. Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology 64:1563–1572
Kile S, Au W, Parise C et al (2017) IVIG treatment of mild cognitive impairment due to Alzheimer’s disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia. J Neurol Neurosurg Psychiatry 88(2):106–112. [Epub ahead of print]
Ferreira D, Westman E, Eyjolfsdottir H et al (2015) Brain changes in Alzheimer’s disease patients with implanted encapsulated cells releasing nerve growth factor. J Alzheimers Dis 43:1059–1072
De Marco M, Shanks MF, Venneri A (2014) Cognitive stimulation: the evidence base for its application in neurodegenerative disease. Curr Alzheimer Res 11:469–483
Erickson KI, Weinstein AM, Lopez OL (2012) Physical activity, brain plasticity, and Alzheimer’s disease. Arch Med Res 43:615–621
Hafkemeijer A, Möller C, Dopper EG et al (2016) Differences in structural covariance brain networks between behavioral variant frontotemporal dementia and Alzheimer’s disease. Hum Brain Mapp 37:978–988
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
De Marco, M., Venneri, A. (2018). Brain Morphometry: Alzheimer’s Disease. In: Spalletta, G., Piras, F., Gili, T. (eds) Brain Morphometry. Neuromethods, vol 136. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7647-8_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7647-8_14
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7645-4
Online ISBN: 978-1-4939-7647-8
eBook Packages: Springer Protocols